Cargando…
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer
Predicting response to endocrine therapy and survival in oestrogen receptor positive breast cancer is a significant clinical challenge and novel prognostic biomarkers are needed. Long-range regulators of gene expression are emerging as promising biomarkers and therapeutic targets for human diseases,...
Autores principales: | Milevskiy, Michael J.G., Al-Ejeh, Fares, Saunus, Jodi M., Northwood, Korinne S., Bailey, Peter J., Betts, Joshua A., McCart Reed, Amy E., Nephew, Kenneth P., Stone, Andrew, Gee, Julia M.W., Dowhan, Dennis H., Dray, Eloise, Shewan, Annette M., French, Juliet D., Edwards, Stacey L., Clark, Susan J., Lakhani, Sunil R., Brown, Melissa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179926/ https://www.ncbi.nlm.nih.gov/pubmed/27378691 http://dx.doi.org/10.1093/hmg/ddw177 |
Ejemplares similares
-
Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017) -
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020) -
Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2019) -
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
por: Milevskiy, Michael J. G., et al.
Publicado: (2019) -
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)